NCH Healthcare System is First in SW Florida to Offer Aquablation Therapy –
A New, Minimally Invasive Treatment for Men with an Enlarged Prostate
Thanks to the generosity of Craig and Pat Jilk, the NCH Healthcare System is proud to announce today that it is the first in Southwest Florida to offer Aquablation therapy for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia (BPH).
BPH, or an enlarged prostate, is a non-cancerous condition where the prostate has grown to be larger than normal. One in two men ages 51 to 60 have BPH, and the incidence increases every decade of life. If left untreated, BPH can cause significant health problems, including irreversible bladder or kidney damage, bladder stones, and incontinence.
Many BPH surgical treatments today often force men to trade off between symptom relief and side effects, limiting patients to choose between either a high degree of symptom relief with high rates of irreversible complications (such as incontinence, erectile dysfunction, or ejaculatory dysfunction) or low degree of symptom relief with low rates of complications.
Aquablation therapy is different. It’s an advanced, minimally invasive treatment that uses the power of water delivered with robotic precision to provide best-in-class and long-lasting symptom relief with low rates of irreversible complications, regardless of prostate size or shape.
Aquablation therapy is performed by the AquaBeam Robotic System, the first FDA-cleared, surgical robot utilizing automated tissue resection for the treatment of lower urinary tract symptoms due to BPH. It combines real-time, multi-dimensional imaging, automated robotic technology, and heat-free waterjet ablation technology for targeted, controlled, and immediate removal of prostate tissue. Aquablation therapy offers predictable and reproducible outcomes, independent of prostate anatomy, prostate size, or surgeon experience.
Aquablation therapy has proven results. In clinical studies, Aquablation therapy has shown to provide both best-in-class and durable symptom relief with low rates of irreversible complications. “We are proud to be the first in Southwest Florida to offer a solution for men with BPH that provides relief without compromise,” said Paul Hiltz, President & CEO, NCH Healthcare System. “As NCH transforms into an Advanced Community Healthcare SystemTM , Aquablation therapy furthers our commitment to providing leading-edge, robotic surgery to improve and optimize the health of men in our community, without them having to travel outside our region to get it.”
For more information on how Aquablation therapy at NCH can work for you, visit us at NCHmd.org, or visit aquablation.com.
FEATURED PHOTO: Paul Hiltz President / CEO
About NCH Healthcare System
The NCH Healthcare System is a not-for-profit, multi-facility healthcare system located in Naples, Florida, and is a member of the Mayo Clinic Care Network. The System is more than just two hospitals (referred to as the NCH Baker Hospital and NCH North Naples Hospital) with a total of 713 beds. NCH is an alliance of 775 physicians and medical facilities in dozens of locations throughout Collier County and southwest Florida that offers nationally recognized, quality health care to our community. Our mission is to help everyone live a longer, happier, healthier life. For more information, visit www.NCHmd.org.
About PROCEPT BioRobotics Corporation
PROCEPT BioRobotics is a surgical robotics company enabling better patient care by developing transformative solutions in urology. With an initial focus on BPH, the AquaBeam Robotic System delivering Aquablation therapy is the first FDA-cleared, surgical robot utilizing automated tissue resection for the treatment of lower urinary tract symptoms due to BPH. Aquablation therapy combines real-time, multi-dimensional imaging, automated robotic technology, and heat-free waterjet ablation technology for targeted, controlled, and immediate removal of prostate tissue. Aquablation therapy offers predictable and reproducible outcomes, independent of prostate anatomy, prostate size, or surgeon experience. For more information visit https://www.procept-biorobotics.com.